177 filings
6-K
IPHA
Innate Pharma
15 Apr 24
Innate Pharma Announces Advancement Of Sanofi-Developed Nk Cell Engager Sar443579 / Iph6101 Progressing To Phase 2 For Blood Cancer Patients
6:02am
6-K
IPHA
Innate Pharma
15 Apr 24
Current report (foreign)
6:00am
6-K
IPHA
Innate Pharma
10 Apr 24
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
6:51am
6-K
IPHA
Innate Pharma
21 Mar 24
Summary of Consolidated Financial Statements and Notes
9:20am
6-K
IPHA
Innate Pharma
21 Mar 24
Innate Pharma reports Full Year 2023 Financial Results and Business Update
6:01am
6-K
v01fika
19 Mar 24
Innate Pharma Announces Its Participation To Upcoming Investor Conference
6:33am
6-K
vzgb2ddand512
14 Mar 24
Innate Pharma Announces Conference Call And Webcast For Full Year 2023 Financial Results
7:00am
6-K
ll2e y62ar
6 Mar 24
Current report (foreign)
6:00am
6-K
ip4kd
6 Mar 24
Current report (foreign)
6:00am
6-K
jidm3 u6y
21 Feb 24
Innate Pharma Announces Its Participation To Upcoming Investor Conference
6:00am
6-K
4zvhf7e6ef uoe2vi
6 Feb 24
Current report (foreign)
5:05pm
6-K
4ydlk7cuwu 0m2ft
12 Jan 24
Innate Pharma S.a. 6-K
6:00am
6-K
1ifc6qelf9lcl4br3f78
5 Jan 24
Innate Pharma S.a. 6-K
6:09am
6-K
epd9qc4cufkuhk4
4 Jan 24
FDA lifts partial clinical hold on lacutamab clinical programFatal case related to disease progression and unrelated to the treatment
6:01am
6-K
a2b8ptw9nq6 z5s1u
4 Jan 24
Innate Pharma 6-K
6:00am
6-K
rbtn9re1cjp7gce7m
20 Dec 23
Current report (foreign)
4:30pm
6-K
h4vg802rr h0
19 Dec 23
Innate Pharma S.a. 6-K
6:00am
6-K
v0830kp
18 Dec 23
Innate Pharma S.a. 6-K
11:40am
6-K
wd2kij 260ox9lgh
11 Dec 23
Innate Pharma S.a. 6-K
6:01am
6-K
d1og0ax lj7h7dzt2
11 Dec 23
Innate Pharma S.a. 6-K
6:00am